Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin vs Misoprostol for PPH in Severe Preeclampsia
NCT02086994Phase 3Completed
- Start
- Mar 2013
- Primary completion
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of carbetocin in postpartum hemorrhage (PPH) (2 arms). Primary endpoint: Incidence of Postpartum Hemorrhage at 24 hours. Started Mar 2013; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02086994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086994.